Related Experiment Video
Updated: Jul 5, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
HOOK3 suppresses proliferation and metastasis in gastric cancer via the SP1/VEGFA axis
Kexi Yang1,2,3, Juntao Li1,2,3, Jinghan Zhu1,2,3
1Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Abstract:
HOOK3, a member of the human hook microtubule-tethering protein family, has been implicated in the progression of cancer. However, the role of HOOK3 in the pathogenesis of gastric cancer (GC) remains incompletely understood. In this study, we investigated the expression of HOOK3 protein in GC tissues using immunohistochemistry (IHC). The findings of our study indicate that the expression levels of HOOK3 in GC tissues were relatively low. Furthermore, a significant negative association was seen between HOOK3 expression and the prognosis of patients with GC. The suppression of HOOK3 resulted in a notable increase in the proliferation, migration, invasion, and survival of GC cells. Conversely, the overexpression of HOOK3 had the opposite impact, reducing these cellular processes. Moreover, in vivo tests have shown evidence that the overexpression of HOOK3 significantly inhibited the formation of tumors and the spread of GC cells to the lungs. In a mechanistic manner, the analysis of RNA-seq data demonstrated that the knockdown of HOOK3 resulted in a notable increase in the expression of vascular endothelial growth factor A (VEGFA) in GC cells. Furthermore, the upregulation of VEGFA counteracted the impacts of HOOK3 upregulation on the proliferation, migration, invasion, and survival of GC cells. Furthermore, it was revealed that specificity protein 1 (SP1) exhibited the ability to bind to the promoter region of VEGFA. Moreover, the overexpression of SP1 successfully counteracted the inhibitory impact of HOOK3 overexpression on the expression of VEGFA in GC cells. In summary, the results of our study indicate that HOOK3 has a role in inhibiting the growth, migration, invasion, and survival of GC cells by modulating the SP1/VEGFA pathway. These findings contribute significant knowledge to our understanding of the underlying mechanisms involved in the development of GC.
Insights
HOOK3 protein suppresses gastric cancer (GC) progression by inhibiting cell proliferation, migration, and invasion. Its downregulation increases tumor growth, while its overexpression inhibits tumors via the SP1/VEGFA pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- HOOK3, a microtubule-tethering protein, is linked to cancer progression.
- The specific role of HOOK3 in gastric cancer (GC) pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the expression and function of HOOK3 in gastric cancer.
- To elucidate the underlying molecular mechanisms of HOOK3's action in GC.
Main Methods:
- Immunohistochemistry (IHC) to assess HOOK3 protein levels in GC tissues.
- In vitro cell culture experiments to evaluate the effects of HOOK3 suppression and overexpression on GC cell behavior.
- In vivo studies to assess tumor formation and metastasis.
- RNA-sequencing (RNA-seq) to identify molecular pathways affected by HOOK3.
- Western blotting and promoter binding assays to confirm molecular interactions.
Main Results:
- HOOK3 expression was low in GC tissues and negatively correlated with patient prognosis.
- HOOK3 suppression enhanced GC cell proliferation, migration, invasion, and survival.
- HOOK3 overexpression inhibited GC cell growth, tumor formation, and lung metastasis.
- HOOK3 knockdown increased VEGFA expression, while HOOK3 overexpression decreased it.
- SP1 binds to the VEGFA promoter and its overexpression counteracted HOOK3's effect on VEGFA levels.
Conclusions:
- HOOK3 acts as a tumor suppressor in gastric cancer.
- HOOK3 inhibits GC progression by downregulating the SP1/VEGFA pathway.
- These findings reveal HOOK3 as a potential therapeutic target for gastric cancer.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
Related Concept Videos
Abnormal Proliferation
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hedgehog Signaling Pathway